2.4 semaglutide mg weekly Efficacy and safety of once-weekly 2·4 versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial Semaglutide 2.4mg Injection at Wegovy was shown to reduce body weight in people with body mass indexes Novo Nordisk study finds greater
Pay in 4 interest-free payments of $5.22 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12










:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)












